Bend Research, part of Capsugel’s Dosage Form Solutions business unit, has added Capsugel’s Xcelodose precision powder-filling technology to its drug development process. This patented micro-dosing technology is intended to enhance Bend’s recently announced Rapid Advancement of Preclinical Compounds initiative. The technology will also facilitate fast and efficient scale up and transfer of powder-fill formulations within Capsugel’s global network of commercial production sites, according to a Be...